Outcomes of reinterventions after subintimal angioplasty  by Schmieder, Gregory C. et al.
From the Society for Clinical Vascular Surgery
Outcomes of reinterventions after subintimal
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Gregory C. Schmieder, MD, Albert I. Richardson, MD, Eric C. Scott, MD, Gordon K. Stokes, MD,
George H. Meier III, MD, and Jean M. Panneton, MD, Norfolk, Va
Objective: With increased use of subintimal angioplasty (SIA), the role of reintervention after recurrence is currently
unknown. To more clearly define the technical feasibility, patency, and clinical outcomes of reinterventions after SIA, we
reviewed our cumulative experience.
Methods: A retrospective review of patient information (including demographics, indications, procedures, noninvasive
arterial studies, and postprocedural events) was performed on those patients undergoing reintervention after a primary
subintimal angioplasty in the infrainguinal vessels. Continuous and noncontinuous data were compared using the
Student t-test and the z test, respectively. Patency was calculated by Kaplan-Meier analysis. Survival curves were compared
using log-rank and Wilcoxon testing for univariate analysis and Cox hazard-regression analysis for multivariate analysis.
Results: FromDecember 2002, through July 2006, 495 SIAs were performed for infrainguinal disease in 482 patients. Of
this cohort, 121 patients (25%) required 188 consecutive reinterventions. Each patient underwent an average of 1.5 0.8
(range, 1-7) reinterventions during this study. We analyzed only the outcomes of 124 consecutive, first reinterventions.
Mean interval time between primary SIA and the first reintervention was 7.8  6.8 months (range, 1 day-31 months).
Indications for reintervention were clinical only (recurrence of symptoms or worsening exam), diagnostics only
(recurrence based on peripheral vascular lab studies), or both in 18%, 25%, and 52% of patients, respectively. Technical
success was achieved in 94% (n  117) of the procedures. Repeat SIA technique was utilized in 68% (n  84) of
reinterventions and other endovascular therapies (32%; n 40), of which the majority were transluminal angioplasty, for
the remaining reinterventions. Mean follow-up was 8.6 months (range, 0-34 months). The patency rate at 1 year for the
first reintervention was 33%. One-year patency rates for reinterventions performed within 3 months of the primary SIA
were worse than those performed after 3 months (22% vs 34%; P .04). In addition, patients treated for claudication had
better 1-year patency than those treated for critical limb ischemia (37% vs 27%; P  .03). Other demographic or
procedural variables did not significantly affect patency. In patients with critical limb ischemia (CLI), limb salvage rate at
1 year was 71%.
Conclusion: Endovascular reintervention after SIA is a safe and technically feasible procedure for recurrences and offers
good limb salvage rate. Early reinterventions performed within 3 months of the original SIA portend a worse outcome.
In addition, reinterventions are less durable in patients with CLI compared with claudication. Finally, by identifying a
recurrent stenosis instead of an occlusion, close surveillance may contribute to improved overall outcome. (J Vasc Surg
2010;52:375-82.)Surgical and endovascular interventions are well-
established therapeutic options for infrainguinal periph-
eral arterial disease. Limitations of open bypass surgery
include surgical site infections and graft thrombosis. Graft
thrombosis has been associated with higher costs and worse
clinical outcomes.1 Surveillance with duplex ultrasound has
been used to maintain patency and improve outcomes for
lower extremity vein bypasses.2,3 Reinterventions to pre-
serve open autologous surgical bypass grafts have been
shown to improve overall outcomes.1,4
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doi:10.1016/j.jvs.2010.03.008One of the limitations of endovascular interventions is
its long-term durability, in which endoluminal restenosis or
occlusions occur. Subintimal angioplasty (SIA) has been
increasingly utilized for TransAtlantic InterSociety Con-
sensus (TASC) C and D infrainguinal occlusions. Primary
patency rates at 1 year have varied between 51% and 85%.4-7
Our experience has shown a primary patency of 55% and
35% at 1 year and 3 years, respectively.8 The outcomes of
reinterventions after SIA failure are currently unknown,
and very little if any data have been published. We reviewed
our cumulative experience to more clearly define the tech-
nical feasibility, patency, and clinical outcomes of endovas-
cular reinterventions after SIA failure.
MATERIALS AND METHODS
A retrospective review was performed on patients with
critical limb ischemia (CLI) or disabling claudication who
underwent a primary subintimal angioplasty from Decem-
ber 1, 2002 through July 31, 2006. Patient demographics,
clinic notes, noninvasive vascular studies, angiographic
findings, and operative reports were reviewed after approval
by the Institutional Review Board.
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rial occlusive disease were treated with SIA in 482 consec-
utive patients. The occluded segments ranged from the
superficial femoral artery to the tibial arteries. This study
focuses only on those limbs in which a first-time reinterven-
tion was attempted after a prior, successful SIA was per-
formed in the infrainguinal vessels; hence, evaluating re-
sults of 124 reinterventions on 121 patients. All procedures
were performed in an angiographic suite. The common
femoral artery contralateral to the treated limb was the
preferred means of angiographic access. After angiography
and identification of an arterial occlusion/stenosis, patients
were systemically heparinized. The occluded or stenotic
segments were typically approached by placement of a
longer sheath over the aortic bifurcation and in proximity
to the lesion. The endovascular technique utilized in each
procedure was determined by the lesion. If there was a
stenosis, every attempt was made to remain “intraluminal.”
Also, the characteristics of the lesion guided use of any
other adjunctive therapies. If there was an occlusion, a
repeat SIA was attempted. A soft, hydrophilic 0.035-inch
guidewire in combination with a 4F or 5F angled hydro-
philic catheter (Glidecath; Terumo Medical Corporation,
Somerset, NJ) were the most commonly used to navigate
through the stenosis or to perform a redo-subintimal dis-
section. After confirmation of traversing the lesion with a
catheter into the true lumen, balloon angioplasty was used
to dilate the area of stenosis or the new subintimal channel.
Other adjunctive devices utilized during reinterventions
included mechanical atherectomy (3), mechanical throm-
bolysis (2), thrombolytic infusion (5), cryoplasty (3), cut-
ting balloon (2), and laser atherectomy (7). Only one
patient underwent a combination procedure of cutting-
balloon, angiojet, and tPA infusion. Self-expanding nitinol
stents were selectively deployed within the treated lesions
for: (1) suboptimal angioplasty, defined as residual stenosis
greater than 30%; and (2) flow-limiting dissection flaps.
Technical success was defined as either the creation of a
subintimal channel bypassing the occlusion, with successful
re-entry into the true lumen and subsequent angioplasty or
intraluminal therapy with a residual stenosis 30% after
intervention. After the procedure, patients received clopi-
dogrel for at least 1 month and aspirin indefinitely. Patients
were allowed to resume ambulation 6 to 8 hours after the
procedure and were typically discharged to home on the
same day or within 24 hours.
Clinical follow-up at 1 month, 3 months, and 6 to 12
months after the procedure was routine and included phys-
ical examination and measurement of ankle-brachial indi-
ces. Duplex examination of the subintimal channel and
further follow-up were obtained at the discretion of the
treating surgeon. Any additional endovascular procedures
to maintain or restore patency of the subintimal channel
were recorded, as were all open surgical revisions, bypasses,
and major amputations performed through July 31, 2007.
Patency of the SIA was defined by at least one of the
following criteria: flow through the vessel demonstrated by
angiography or duplex angiography (50% stenosis de-fined by doubling of peak systolic velocity [PSV]), mainte-
nance of an ankle-brachial index greater than 0.10 above
the preprocedural value, or maintenance of a palpable pedal
pulse that was absent before the procedure in an asymp-
tomatic patient. Resolution of symptoms was not consid-
ered an indication of patency. Any follow-up intervention
necessitating open surgical revision or bypass was reported
as such and was not included in primary assisted or second-
ary patency. Only repeat endovascular procedures were
included in calculating primary assisted and secondary pa-
tency rates.
Continuous data are expressed as mean SD and were
compared by using the Student t-test. Noncontinuous data
are expressed as percentages and were compared by using
the z test comparison for proportions. P .05 was consid-
ered statistically significant. Patency, limb salvage, symp-
tomatic improvement, and freedom from surgical bypass
were determined with Kaplan-Meier survival analysis and
compared by log-rank and Wilcoxon testing. Multivariate
analysis was performed by Cox proportional hazards regres-
sion. Patency is presented in terms of technical success.
RESULTS
Analysis of reintervention vs no reintervention.
During this study period, 495 SIA for infrainguinal arterial
occlusive diseasewere performedon482 consecutive patients.
Reintervention was performed in only 25% (124 limbs in 121
patients) of this population.Thedemographics for each group
are displayed in Table I. The mean age at reintervention was
70  11.6 years compared with 69.5  12.5 years for no
reintervention (P .65).Therewere no statistically significant
differences in risk factors between the two groups. The broad
indications for the procedure were similar between the two
groups (eg, presence of CLI in the reintervention [60%] vs no
reintervention groups [63%;P .61]). There was, however, a
trend within the CLI category for more patients in the no
reintervention group to have undergone treatment for gan-
grene than the reintervention group (14% vs 7%; P  .055).
More patients in the no-reintervention groupwere treated for
superficial femoral artery (SFA) only lesions than the reinter-
vention group (41% vs 18%; P  .01). In contrast, more
patients in the reintervention group were treated for SFA-
popliteal lesion than the no reintervention group (62% vs 34%;
P .01).
Of the 371 patients in the no reintervention group,
there were 89 who had loss of SIA patency. The outcomes
of these 89 patients were progression to amputation (19),
surgical bypass (28), death (6), and no measureable clinical
end point (36). The patients who died or progressed im-
mediately to amputation were poor operative candidates
with CLI and tibial vessel disease. Half of the patients
who underwent surgical bypass or no further treatments
were claudicants. Only 1 of 16 patients with CLI who
had a surgical bypass progressed to amputation.
A total of 33 surgical bypasses were performed in the no
reintervention group. Twenty-eight were performed after
loss of SIA patency as stated above. Five bypasses were
performed in patent SIA without clinical improvement.
plasty
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period, 188 reinterventions were performed on 121
patients—hence, a mean of 1.5  0.8 reinterventions per
patient. Further analysis will only focus on the first reinter-
ventions (124 interventions in 121 patients). The mean
time to reintervention was 7.8  6.8 months after primary
SIA (Table II). At the time of reintervention, 61% (n 75)
of SIA channels were occluded, whereas the other 39% (n
49) had one or more areas of restenosis. Patients with index
SIA stents (17/29) had a similar percentage of occlusion at
time of reintervention as those without a stent (59/95) at
the index SIA (59% prior stent vs 62% no stent; P  NS).
Redo SIA was performed on 84 limbs, whereas 40 limbs
underwent intraluminal therapies. Being unable stay in-
traluminal, nine patients with stenosis underwent a redo
SIA. These intraluminal therapies were predominantly bal-
loon angioplasty (98%; n  39); however, a few cases used
adjunctive techniques such as mechanical atherectomy (1/
40), laser atherectomy (3/40), cryoplasty (2/40), and/or
tPA infusion (1/40). Stents were utilized more frequently
at the time of reintervention compared to the time of
primary SIA (45% vs 25%, respectively; P  .002). Also,
stent use increased if the original SIA channel was occluded
versus restenosis (51% [42/76] vs 21% [10/48]; P .01).
Table I. Patient demographics and risk factors for periphe
Variable
Reintervention
(124 limbs; 121 pati
Age (y)
Mean  SD 70  11.6
Range 41.8-97.5
Gender
Male 56% (68)
Female 44% (53)
Location of lesion
SFA only 18% (21)
SFA-popliteal 63% (73)
SFA-popliteal-infrapopliteal 9% (11)
Popliteal only 2% (2)
Popliteal-infrapopliteal 4% (5)
Infrapopliteal 4% (5)
Indication
Critical limb ischemia 60% (72)
Rest pain 27% (32)
Ulceration 26% (31)
Gangrene 7% (9)
Claudication 40% (49)
Risk factors
Hypertension 68% (92)
Diabetes mellitus 50% (56)
Coronary artery disease 53% (65)
History of smoking 46% (59)
End-stage renal disease 11% (13)
Hyperlipidemia 35% (55)
Previous LE bypass 27% (32)
Nonoperative candidate 13% (16)
Stent placement at primary
SIA
25% (29)
LE, Lower extremity; SFA, superficial femoral artery; SIA, subintimal angio
aPatient demographics calculated by number of patients; procedural characThemajority of stents were placed in the superficial femoraland popliteal artery above the knee. There were 20 stents
placed in the popliteal artery (five below knee), and three
stents placed in a tibial vessel.
The majority of patients underwent reintervention
based on a clinical and diagnostic study change (52%).
Other reasons for reintervention were diagnostic study
change ([decrease in ABI 0.1 or doubling of PSV on arterial
duplex] only [25%]), clinical change ([failure to heal or loss
of pulse] only [18%]), and acute ischemia (1%). Forty-five
patients (36%) had 1-vessel runoff at time of reinterven-
tion, whereas 59 patients (48%) had 2-vessel runoff.
Overall technical success was achieved in 94% (n 117) of
cases. A total of seven technical failures occurred during the
study. Six failures were due to the inability to cross the
lesion or re-enter into the true lumen; these patients pro-
ceeded to open bypass surgery. The other failure was due to
an uncooperative patient; a successful endovascular proce-
dure was performed at a later date. There were no statisti-
cally significant differences in technical success comparing
the different techniques used, the prior use of stent, nor the
status of the SIA channel at time of reintervention (oc-
cluded vs stenosis). Of the seven failures, only one proceeded
to below-knee amputation 6 months later because of poor
distal targets. The other six patients underwent femoro-
rterial disease
a
No reinterventions
(371 limbs; 353 patients) P value
69.5  12.5 .65
36.8-98.9
54% (189) .61
46% (164) .61
41% (154) .01
34% (125) .01
10% (39) .60
3% (10) .50
4% (15) .99
8% (28) .17
63% (236) .27
22% (83) .43
27% (102) .59
14% (51) .055
36% (133) .46
71% (251) .30
51% (180) .37
53% (188) .93
44% (157) .41
13% (47) .46
38% (133) .13
20% (71) .15
14% (51) .74
22% (83) .82
.
s calculated by number of limbs.ral a
s
ents)popliteal (1), femorotibial (4), and popliteal-peroneal (1)
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ceeded toward below-knee amputations at 1.5 and 3 years
later. In total, three of seven patients eventually required
amputations. There were no periprocedural deaths at 30
days. There were four periprocedural complications (two
emboli, one arteriovenous fistula, and one wire fracture),
none of which required surgical intervention.
Mean follow-up was 8.6 months (range, 0-34months).
Primary patency after reintervention was 33% at 1 year (Fig.
1). Patients undergoing reintervention within 3 months of
their primary SIA had worse 1-year patency rates than those
with reinterventions after 3 months (22% vs 34%; P  .04;
Fig. 2). Patients intervened upon for claudication had
better 1-year patency than those intervened upon for CLI
(37% vs 27%; P  .03; Fig. 3). There was also a trend for
worse 1-year patency in patients with occluded SIA channel
compared to those with stenosis (29% vs 37%; P  .11).
Other demographic and procedural factors did not affect
patency rates by univariate analysis (Table III). Multivariate
Table II. Procedural details
Variable Data
Time to reintervention
Mean 7.8  6.8 months
Range 0.03-30.72 months
Technique
Redo SIA 68% (84)
Adjuncts
Cryoplasty 1% (1/84)
Laser atherectomy 5% (4/84)
Mechanical atherectomy 2% (2/84)
Thrombolytic infusion 6% (5/84)
Mechanical thrombectomy 4% (3/84)
Cutting-balloon angioplasty 2% (2/84)
Other 32% (40)
Intraluminal angioplasty 98% (39/40)
Cryoplasty 5% (2/40)
Laser atherectomy 8% (3/40)
Mechanical atherectomy 3% (1/40)
Thrombolytic infusion 3% (1/40)
Mechanical thrombectomy 0% (0/40)
Cutting-balloon angioplasty 0% (0/40)
Reason for reintervention
Acute ischemia 1% (1)
Clinical change only 18% (22)
Diagnostic study change only 25% (31)
Both (clinical and diagnostic) 52% (64)
SIA channel status
Occlusion 61% (76)
Stenosis 39% (48)
Technical success
Overall 94% (117)
SIA technique 93% (78/84)
Other technique 98% (39/40)
Previous stent 93% (27/29)
No previous stent 95% (90/95)
Stent placement at reintervention 45% (52)
Vessel runoff
1 36% (45)
2 48% (59)
SIA, Subintimal angioplasty.analysis did not reveal any significant factors affecting pa-tency (Table IV). Limb salvage for patients with CLI was
71% at 1 year (Fig. 4). Finally, survival at 1 year was 90%.
Twenty patients after reintervention required surgical
bypass. Eight were performed for claudication, whereas 12
were performed for CLI (gangrene, 1; rest pain, 7; and
ulceration, 4). One patient required an amputation 9
months after bypass. Sixteen patients, all of whom had CLI
(41% [4/9] gangrene, 6% [2/33] rest pain, and 31% [10/
32] ulcerations), required amputation after reintervention.
Ten of the sixteen patients were nonoperative candidates,
two of which had unsuccessful redo SIA. The remaining six
patients presented with ulceration and required amputation
at a mean of 8 months postreintervention.
DISCUSSION
SIA is an endovascular technique utilized for revas-
cularization of TASC C or D lesions. Our group, along
with many others, has increasingly used this technique
for chronic arterial occlusions.4,5,7,8 How to manage
recurrence after SIA is currently unknown. Endovascular
techniques have been used to salvage surgical bypass
grafts with recurrent stenosis or occlusion. This study
shows that endovascular reinterventions after SIA are
safe, feasible, and provide good limb salvage in a difficult
patient population.
During the study, only 25% of patients who under-
went SIA required a reintervention. This percentage is
similar to studies on reintervention for surgical bypasses,
where approximately 15% to 20% undergo revision.9-11
The mean time to reintervention, however, is much shorter
for SIA at 7.8 months compared with surgical bypass at 12
to 15 months. There were no statistically significant differ-
ences in risk factors or disease classification in patients who
underwent bypass versus reintervention. Our data for clas-
sification do not include a scale for severity. This is an
interesting question that we are still trying to figure out
clinically. Our paper shows that lesions located in the
SFA-popliteal location require more reinterventions than
those located solely in the SFA. This may reflect the com-
plexity of the lesion or lesion length in the SFA-popliteal
location. This study also shows a 1-year primary patency of
33% after reintervention. This patency is inferior to our
previously published 1-year patency rates after index SIA
cases of 55%.8 Inferior patency rates after reintervention
have also been seen in open and endovascular therapy for
failing surgical bypass grafts.1,9-11 These reinterventions,
however, can provide good limb salvage and clinical out-
comes without the cost and morbidity of open redo by-
passes.12,13 There are several reasons for inferior patency
rates after reintervention. First, patients may have had
continued progression of distal disease, which decreases
outflow and may worsen outcomes. Second, the initial SIA
channel may start up an inflammatory response leading to
neointimal hyperplasia. Early recurrence may also be a
marker for patients with worse disease or inflammatory
response to SIA. Hence, these patients may have a predis-
position to a worse outcome compared with patients with-
out recurrence. Third, the creation of the index SIA chan-
nterv
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the disease in the vessel. This would be equivalent to a poor
venous conduit. Therefore, any reintervention in a poor
Fig 1. Primary patency after rei
Fig 2. Primary patency after reintervention by time int
(P  .04).conduit would have an expected worse outcome. All ofthese components would make it more difficult to achieve
an optimal result after reintervention.
Despite the low patency rate, limb salvage at 1 year
ention. One-year patency: 33%.
One-year patency: 3 months 34% vs 3 months 22%erval.remained very good for CLI patients. This limb salvage
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(71% vs 87%).8 This pattern of decreased limb salvage rate
after reintervention has also been seen in open and endolu-
minal interventions after failing surgical bypass.1,9-11 Tech-
nical success for reintervention was better than that for
index SIA (94% vs 87%).8 Only one patient required an
Fig 3. Primary patency after reintervention by indication
27% (P  .03).
Table III. Univariate analysis of risk factors for loss of
patency after reintervention
Risk factor
Hazard
ratio
95%
confidence
interval P value
Coronary artery disease 0.98 0.58-1.64 .93
Female 1.47 0.89-2.54 .13
African American 1.22 0.71-2.15 .45
Hypertension 1.04 0.56-1.92 .90
Age 80 1.54 0.87-3.11 .13
Smoking 0.79 0.47-1.32 .52
Hyperlipidemia 0.93 0.56-1.56 .79
End-stage renal disease 1.94 0.81-7.78 .11
Diabetes mellitus 0.79 0.47-1.32 .36
Prior bypass surgery 1.05 0.60-1.85 .85
Critical limb ischemia 1.75 1.05-2.94 .05
Nonoperative candidate 0.53 0.27-1.32 .21
Previous stent 1.41 0.74-2.94 .27
Time interval 3 months 1.62 0.87-3.69 .05
SIA status-occluded 1.52 0.89-2.55 .11
SFA-popliteal location 1.64 0.81-3.23 .18
No stent use 1.27 0.76-2.14 .37
Redo SIA 1.12 0.65-2.06 .68
Vessel runoff 1 1.15 0.65-2.06 .61
SFA, Superficial femoral artery; SIA, subintimal angioplasty.outback catheter to achieve re-entry. This may be due tothe previous subintimal channel allowing for an easier
traverse of the lesion. In addition, all index SIAs are per-
formed on chronic total occlusions, whereas reinterven-
tions were performed for stenosis and occlusions in 40%
and 60% of patients, respectively. Our approach for a redo
SIA is the same as our approach to an index SIA. The
important aspects for a SIA include a stable working sheath,
which allows for good pushability and continued practice.
The only possible differences between a redo SIA and index
SIA are using a different wire and the amount of force.
Interestingly, we did not find a difference in technical
success if a stent was previously placed at the index SIA. In
a previous article, we found that selective stents placed for
suboptimal results after subintimal angioplasty produced
similar patency rates to primary SIA without stenting.14
This article shows that previous stent placement does not
appear to affect the feasibility of reintervention. There were
no cases of redo SIA channel outside a previous stent.
Finally, these reinterventions were performed with no peri-
procedural (30 days) deaths. Lower mortality has also
been seen in endoluminal interventions for surgical bypass
compared with open revisions.9
In our series, reinterventions for early SIA failures (3
months) have worse outcomes than for late failures (3
months). Interventions after surgical bypass have also had
similar worse outcomes for early failure; however, early
failure for surgical bypass is usually described as 6
months.1,9-11 Early failure after SIAmay reflect either more
advanced disease, more severe inflammatory response, or
inadequate initial procedure; hence, leading to a worse
e-year patency: claudication 37% vs critical limb ischemia. Onoutcome after reintervention. This study also found a worse
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and others as well have also found worse outcomes in CLI
patients after index SIA.8,15-16
Duplex ultrasound surveillance after open surgical by-
pass has shown improved long-term outcomes.2-3 Part of
this benefit is thought to derive from intervening on a
lesion before graft occlusion. This study does not prove the
value of surveillance after SIA; it does suggest better pa-
tency if reintervention on SIA channels are undertaken with
stenosis versus occlusion. Interventions on surgical by-
passes for occlusion have similar poor outcomes.1,10 The
important question regarding surveillance of SIA remains
what to do with the result. If the patient is symptomatic
with or without duplex changes, an angiogram with possi-
ble reintervention is warranted. The controversy lies within
the patient who is asymptomatic but has a stenosis or
occlusion on duplex ultrasonography. Out of 371 patients
without intervention, 21 patients with loss of SIA patency
and no symptoms did not progress to any further treat-
ments. The follow-up period for this group is relatively
short (6 months). This may simply reflect the lack of
follow-up with patients. Hence, no real conclusions can be
Table IV. Multivariate analysis of risk factors for loss of p
Risk factor b SE
Occluded SIA channel 0.46 0.28
Critical limb ischemia 0.51 0.30
Time interval 3 months 0.27 0.34
SIA, Subintimal angioplasty.
Fig 4. Limb salvage (dashed line) for CLI and overa
salvage 71%; 1-year survival 90%.made regarding the loss of a patent SIA without symptomsfrom this study. Whether reintervention will provide a
better clinical or technical outcome is currently unknown at
this time. Finally, our experience has also shown that SIA
occlusion rarely leads to acute ischemia, unlike open by-
passes (ie, “goes down softer”). The putative reasons may
be preservation of collaterals or segmental occlusion of SIA
channel compared with occlusion of the entire length of the
bypass graft.17
Limitations of our study are several. First, its retrospec-
tive design contributed to incomplete data collection for
some preprocedural and postprocedural variables. This
could result in underestimation of patency based on clinical
follow-up. Second, several different techniques were uti-
lized for reintervention. In addition, this study included
treated segments from the proximal SFA to the tibial ves-
sels. This heterogeneous data could make interpretation of
outcomes more difficult. This study, however, does reflect
clinical practice in a difficult subset of patients. Third,
there were no established selection criteria for reinter-
vention. This makes it difficult to gain conclusions about
which patients would benefit most and least from a
reintervention. Finally, mean follow-up was relatively
y patency after reintervention
Exp(b) 95% confidence interval P value
1.58 0.91-2.75 .11
1.66 0.93-2.97 .09
1.31 0.67-2.97 .43
vival (solid line) after reintervention. One-year limbrimarll surshort, approximately 8 months. Therefore, this study
JOURNAL OF VASCULAR SURGERY
August 2010382 Schmieder et alcannot predict the long-term outcomes or benefits of
reintervention after SIA.
CONCLUSIONS
Endovascular reintervention after SIA is a safe and
technically feasible procedure for recurrences and offers a
very good limb salvage rate. Early reinterventions per-
formed within 3 months of the original SIA portend a
worse outcome. In addition, reinterventions are less dura-
ble in patients with CLI compared with claudication. Fi-
nally, by identifying a recurrent stenosis instead of an
occlusion, close surveillance may contribute to improved
overall outcome.
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